Moderna, Inc. MRNA stock is trading lower on Monday. The COVID-19 vaccine maker and Merck & Co Inc. MRK reported five-year ...

We recently compiled a list of the 8 Best Immunology Stocks to Buy According to Hedge Funds. Moderna, Inc. (NASDAQ:MRNA) is ...

Moderna Inc. (NASDAQ:MRNA) is one of the 10 Stocks With Remarkable Resilience. Moderna snapped a four-day losing streak on ...

Coalition for Epidemic Preparedness Innovations funding builds on Moderna's prior filovirus research and supports ...

Japan’s Takeda Pharmaceutical Co. Ltd. said on Friday that “human error” caused metal contaminants to get into Moderna Inc.

CAMBRIDGE, MA / ACCESS Newswire / June 2, 2026 / Moderna, Inc. (Nasdaq:MRNA), today announced its participation in the ...

Moderna (MRNA) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over ...

Moderna Inc.’s experimental flu shot made with mRNA technology will be reviewed by a Food and Drug Administration advisory panel next month, a sign that the agency may be increasing transparency into ...

Moderna, Inc. (NASDAQ:MRNA) revealed topline results on Wednesday from a Phase 3 trial evaluating the efficacy of mRNA-1647, the company’s investigational cytomegalovirus (CMV) vaccine. CMV is a ...

Moderna Inc. MRNA will have its experimental mRNA-based flu vaccine reviewed by a Food and Drug Administration (FDA) advisory ...

According to TipRanks.com, Yee is a 2-star analyst with an average return of 0.4% and a 43.5% success rate. Yee covers the Healthcare sector, focusing on stocks such as Vertex Pharmaceuticals, ALX ...

My name is Gena Wang. I'm SMID Cap biotech analyst at the Barclays. Thank you for joining our call today. We are very pleased to continue our 8th annual speaking science conference call series. Our ...